Literature DB >> 25353720

Two Cases of Rhabdomyolysis After Training With Electromyostimulation by 2 Young Male Professional Soccer Players.

Andreas Kästner1, Markus Braun, Tim Meyer.   

Abstract

We report 2 cases of enormously elevated creatine kinase (CK) activity after training with electromyostimulation (EMS) by 2 young male professional soccer players. In one of them, a single training session with EMS caused exercise-induced rhabdomyolysis with a maximal CK activity of 240 000 U/L. These cases illustrate that unaccustomed EMS exercise may be harmful and can cause rhabdomyolysis even in highly trained athletes and even after 1 single session. Thus, EMS has to be conducted carefully especially by individuals who are known to frequently show notable increases in CK activity even after modest training stimuli. We suggest that EMS should not be applied as sole training stimulus and should not be conducted by strength training beginners. Furthermore, we recommend controlling plasma CK activity and urine color for beginners with EMS when they report strong muscle ache. Athletes with signs of rhabdomyolysis after EMS should be brought to hospital for monitoring of renal function and possible further treatment.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25353720     DOI: 10.1097/JSM.0000000000000153

Source DB:  PubMed          Journal:  Clin J Sport Med        ISSN: 1050-642X            Impact factor:   3.638


  14 in total

1.  [(Very) high Creatinkinase concentration after exertional whole-body electromyostimulation application: health risks and longitudinal adaptations].

Authors:  Wolfgang Kemmler; Marc Teschler; Michael Bebenek; Simon von Stengel
Journal:  Wien Med Wochenschr       Date:  2015-10-26

2.  Can A Superimposed Whole-Body Electromyostimulation Intervention Enhance the Effects of a 10-Week Athletic Strength Training in Youth Elite Soccer Players?

Authors:  Oliver Ludwig; Joshua Berger; Torsten Schuh; Marco Backfisch; Stephan Becker; Michael Fröhlich
Journal:  J Sports Sci Med       Date:  2020-08-13       Impact factor: 2.988

3.  Acute myopathy as a side effect of electrostimulation.

Authors:  Claudia Stöllberger; Josef Finsterer
Journal:  Wien Med Wochenschr       Date:  2018-02-19

4.  Response to the letter of Stoellberger et al. "Acute myopathy as a side effect of electromyostimulation".

Authors:  Wolfgang Kemmler; Simon von Stengel
Journal:  Wien Med Wochenschr       Date:  2018-03-20

5.  The efficacy and safety of whole-body electromyostimulation in applying to human body: based from graded exercise test.

Authors:  Yong-Seok Jee
Journal:  J Exerc Rehabil       Date:  2018-02-26

6.  Efficacy and Safety of Low Frequency Whole-Body Electromyostimulation (WB-EMS) to Improve Health-Related Outcomes in Non-athletic Adults. A Systematic Review.

Authors:  Wolfgang Kemmler; Anja Weissenfels; Sebastian Willert; Mahdieh Shojaa; Simon von Stengel; Andre Filipovic; Heinz Kleinöder; Joshua Berger; Michael Fröhlich
Journal:  Front Physiol       Date:  2018-05-23       Impact factor: 4.566

7.  Safety of a Combined WB-EMS and High-Protein Diet Intervention in Sarcopenic Obese Elderly Men.

Authors:  Wolfgang Kemmler; Simon von Stengel; Matthias Kohl; Nicolas Rohleder; Thomas Bertsch; Cornel C Sieber; Ellen Freiberger; Robert Kob
Journal:  Clin Interv Aging       Date:  2020-06-24       Impact factor: 4.458

8.  Electromyostimulation to fight atrophy and to build muscle: facts and numbers.

Authors:  Volker Adams
Journal:  J Cachexia Sarcopenia Muscle       Date:  2018-07-20       Impact factor: 12.910

Review 9.  (Whole-Body) Electromyostimulation, Muscle Damage, and Immune System: A Mini Review.

Authors:  Marc Teschler; Frank C Mooren
Journal:  Front Physiol       Date:  2019-11-29       Impact factor: 4.566

10.  Effects of Whole-Body Electromyostimulation versus High-Intensity Resistance Exercise on Body Composition and Strength: A Randomized Controlled Study.

Authors:  Wolfgang Kemmler; Marc Teschler; Anja Weißenfels; Michael Bebenek; Michael Fröhlich; Matthias Kohl; Simon von Stengel
Journal:  Evid Based Complement Alternat Med       Date:  2016-02-29       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.